Warning and Advisories for Healthcare Providers > Letters to Healthcare Providers

Letters to Healthcare Providers   Bortezomib: Assessing the Potential Risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) (Letter to Healthcare Professionals)       Attachment: Bortezomib: Assessing the Potential Risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) (Letter to Healthcare Professionals)   Related Information: Canada: Summary Safety Review: Bortezomib: Assessing the potential risk of drug ... Posted 2026-03-27